Literature DB >> 20712455

The lambda interferons: guardians of the immune-epithelial interface and the T-helper 2 response.

Grant Gallagher1, Nicholas J Megjugorac, Raymond Y Yu, Joyce Eskdale, Grant E Gallagher, Rachael Siegel, Elizabeth Tollar.   

Abstract

The type-III interferons (IFNs) are the most recently discovered IFNs in the human immune system and have important, but as yet poorly characterized, functions in innate and adaptive immunity that complement their antiviral functions. It is now becoming clear that these type-III IFNs have a functional niche where epithelial surfaces interact with the adaptive immune system, that their antiviral capability is not as highly developed as that of the type-I IFNs, and that they have their own profile of immunomodulatory functions; specifically, they are key modulators of the T-helper (Th)2 response.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20712455     DOI: 10.1089/jir.2010.0081

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  14 in total

1.  Immune Cell Profiling of IFN-λ Response Shows pDCs Express Highest Level of IFN-λR1 and Are Directly Responsive via the JAK-STAT Pathway.

Authors:  Aoife Kelly; Mark W Robinson; Gerard Roche; Christine A Biron; Cliona O'Farrelly; Elizabeth J Ryan
Journal:  J Interferon Cytokine Res       Date:  2016-09-12       Impact factor: 2.607

2.  Induction of type I interferon signaling by Pseudomonas aeruginosa is diminished in cystic fibrosis epithelial cells.

Authors:  Dane Parker; Taylor S Cohen; Morten Alhede; Bryan S Harfenist; Francis J Martin; Alice Prince
Journal:  Am J Respir Cell Mol Biol       Date:  2012-01       Impact factor: 6.914

Review 3.  Interferon-λs: special immunomodulatory agents and potential therapeutic targets.

Authors:  Ya-wen Zheng; Hui Li; Jin-pu Yu; Hua Zhao; Shizhen Emily Wang; Xiu-bao Ren
Journal:  J Innate Immun       Date:  2012-11-30       Impact factor: 7.349

4.  Borrelia burgdorferi RNA induces type I and III interferons via Toll-like receptor 7 and contributes to production of NF-κB-dependent cytokines.

Authors:  Andrea C Love; Ira Schwartz; Mary M Petzke
Journal:  Infect Immun       Date:  2014-03-24       Impact factor: 3.441

5.  Role of IL28B gene polymorphism and cell-mediated immunity in spontaneous resolution of acute hepatitis C.

Authors:  Enea Spada; Pietro Amoroso; Gloria Taliani; Ornella Zuccaro; Piergiorgio Chiriacò; Patrizia Maio; Giuseppe Maio; Maria Luisa Esposito; Corrado Mariano; Roberto Rinaldi; Pietro Bellissima; Maria Elena Tosti; Paola Del Porto; Ruggiero Francavilla; Vincenzo Mellace; Anna Rosa Garbuglia; Antonella Folgori; Alfonso Mele
Journal:  Clin Infect Dis       Date:  2013-06-19       Impact factor: 9.079

6.  Activation of type III interferon genes by pathogenic bacteria in infected epithelial cells and mouse placenta.

Authors:  Hélène Bierne; Laetitia Travier; Tanel Mahlakõiv; Ludovic Tailleux; Agathe Subtil; Alice Lebreton; Anupam Paliwal; Brigitte Gicquel; Peter Staeheli; Marc Lecuit; Pascale Cossart
Journal:  PLoS One       Date:  2012-06-14       Impact factor: 3.240

Review 7.  Interferon-λ: Immune Functions at Barrier Surfaces and Beyond.

Authors:  Helen M Lazear; Timothy J Nice; Michael S Diamond
Journal:  Immunity       Date:  2015-07-21       Impact factor: 31.745

Review 8.  The impact of the interferon-lambda family on the innate and adaptive immune response to viral infections.

Authors:  Adrian Egli; Deanna M Santer; Daire O'Shea; D Lorne Tyrrell; Michael Houghton
Journal:  Emerg Microbes Infect       Date:  2014-07-16       Impact factor: 7.163

9.  Bacterial pathogens activate a common inflammatory pathway through IFNλ regulation of PDCD4.

Authors:  Taylor S Cohen; Alice S Prince
Journal:  PLoS Pathog       Date:  2013-10-03       Impact factor: 6.823

10.  Design and evaluation of novel interferon lambda analogs with enhanced antiviral activity and improved drug attributes.

Authors:  Debin Yu; Mingzhi Zhao; Liwei Dong; Lu Zhao; Mingwei Zou; Hetong Sun; Mengying Zhang; Hongyu Liu; Zhihua Zou
Journal:  Drug Des Devel Ther       Date:  2016-01-06       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.